Blood derivative in-vitro diagnostic substances manufacturing · New York

Ortho Clinical Diagnostics B313

Name: Ortho Clinical Diagnostics B313 Workplace Safety Data
Creator: PlainSafetyScore
License: https://creativecommons.org/publicdomain/zero/1.0/

Rochester, NY · ~562 workers · 4 years of OSHA Injury Tracking Application data.

Compiled by PlainSafetyScore · August 25, 2026

B
Good Safety Record: 2.2
Avg TCR: 3.3
Industry avg: 0
Fatalities

Subscribe to safety-record updates (RSS)

The verdict

Ortho Clinical Diagnostics B313 runs at 68% of its industry's injury rate - safer than the typical Blood derivative in-vitro diagnostic substances manufacturing workplace, earning a grade B.

Ortho Clinical Diagnostics B313: 2.2 TCR = 68% of Blood derivative in-vitro diagnostic substances manufacturing BLS 3.3 · 4y Form 300A (see methodology below)

Ortho Clinical Diagnostics B313 safety composite

Ortho Clinical Diagnostics B313 scores strongest on fatalities (safer than 50% of same-industry peers) and weakest on dart rate (safer than 18%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

29/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR): F 2.23 per 100 workers

Safer than 25% of industry peers
DART rate: F 2.11 per 100 workers

Safer than 18% of industry peers
Fatalities: D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Rising injury rate

Ortho Clinical Diagnostics B313: 0.7 → 3.1 TCR

Peak year 2022 @ 3.1 TCR · DART/TCR 0.95× in 2022

Ortho Clinical Diagnostics B313's TCR rose 2.4 from 0.7 in 2019 to 3.1 in 2022. In 2022, DART was 0.95× this establishment's average TCR (severity share of cases).

OSHA ITA Form 300A scorecard

Establishment book 325413 · Rochester, NY AT/BELOW-IND · MID

Grade B · TCR 2.2 · 68% of ind

DART 2.1 DART
RANK #12/14
PHOTO Streck Campus
BOOK 4y book
INJ 42 inj
SIZE ~562 FTE

Nearest TCR peer: Streck Campus (0.0 TCR gap)

Read with this employer → · Industry book → · New York employers → · Look up another →

Streck Campus

2.3
This site

2.2
Roche Molecula

2.2
Instrumentatio

2.2
InBios Interna

2.2

What this shows Ortho Clinical Diagnostics B313 averages 2.2 TCR (68% of the Blood derivative in-vitro diagnostic substances manufacturing BLS benchmark).

Ortho Clinical Diagnostics B313 TCR series: 2019=0.7 · 2020=2.2 · 2021=3 · 2022=3.1 · BLS 3.3

Where Ortho Clinical Diagnostics B313 falls in its industry

201 Blood derivative in-vitro diag establishments

Safer than 25% of graded establishments in this industry, whose median TCR is 1.4.

Grade B

More dangerous than peersSafer than peers

Narrower to New York alone (the establishments it most directly competes with for workers and contracts): ranked #12 safest of 14 Blood derivative in-vitro diag employers in New York.

Ortho Clinical Diagnostics B313 (562 employees, TCR 2.2) among 29 same-industry peers, split at the industry median of 120 employees and a TCR of 1.4

Ortho Clinical Diagnostics B313 has more employees than the Blood derivative in-vitro diagnostic sub median and a higher injury rate than the industry's median TCR of 1.4. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year	TCR	DART	Injuries	Illnesses
2022	3.1	2.1	15	1
2021	3.0	1.8	13	4
2020	2.2	1.8	10	2
2019	0.7	0.5	4	0

OSHA ITA peer cross-reference

Establishment peer ledger

325413 · NY · Rochester

201 Blood derivative in-vitro diagnostic substances manufacturing employers nationwide with a credible TCR · 21,008 rated employers in New York with headcount on file · 956 employers in Rochester, NY · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel	Establishment	Place	Metric
NAICS-TCR	Streck Campus	LAVISTA, NE	2.3 TCR
NAICS-TCR	Roche Molecular Systems Branchburg Site	BRANCHBURG, NJ	2.2 TCR
NAICS-TCR	Instrumentation Laboratory	ORANGEBURG, NY	2.2 TCR
NAICS-TCR	InBios International Inc. 307 Facility	SEATTLE, WA	2.2 TCR
STATE-SIZE	Rochester	WEST HENRIETTA	562 FTE
STATE-SIZE	N Amityville NY 1500 New Horizons Blvd	NORTH AMITYVILLE	562 FTE
STATE-SIZE	1849 - Atlantic Terminal	BROOKLYN	562 FTE
STATE-SIZE	WM 1810	FISHKILL	562 FTE
CITY-NEAR	Division 50 University of Rochester	Rochester	13,244 FTE
CITY-NEAR	Rochester General Hospital	Rochester	7,833 FTE
CITY-NEAR	Division 40 University of Rochester	Rochester	4,884 FTE
CITY-NEAR	Unity Hospital	Rochester	3,158 FTE
NAT-TCR	Bio Springer North America Corporation	Cedar Rapids, IA	2.2 TCR
NAT-TCR	Bryan, Texas	Bryan, TX	2.2 TCR
NAT-TCR	Federal-Mogul Manitowoc	Manitowoc, WI	2.2 TCR
NAT-TCR	S05397 - Southern Services Landfill	Nashville, TN	2.2 TCR
NAT-SIZE	Loretto Hospital	Chicago, IL	562 FTE
NAT-SIZE	Logan facility	Logan, UT	562 FTE
NAT-SIZE	Noble House Home Furnishings	Chatsworth, CA	562 FTE
NAT-SIZE	Paris Plant	Paris, TN	562 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2022, 2021, 2020, 2019. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.